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ABSTRACT 
Background: Sepsis, a syndrome characterized by a systemic, (often overwhelming) 
inflammatory response to infection is an under recognized, potentially lethal, public health 
problem in developed and developing countries. Furthermore, is unlikely that it will improve, as 
other than standard critical care support, there are no effective specific treatment strategies. Most 
of the therapeutic trials conducted in the last four decades, other than the lack of benefit, have 
consistently shown that subgroups of septic patients respond differently to the same treatment. 
This has lead to the thought that sepsis may not be a unique syndrome only differentiated by 
grades of severity, but rather a syndrome that encompasses diverse phenotypes that behave 
differently and thus may respond different not only to injury but also to treatment. Thus, the aim 
of this study is to explore if distinct phenotypes exist in a cohort of critically ill patients with 
suspected sepsis, and if these can be identified through clinical available data. This is highly 
relevant to the public health aspect of Sepsis, as it challenges the current paradigm, and provides 
the basis to develop a new approach that may lead finally to an effective reduction of morbidity 
and mortality. Methods: We used a large database of critically ill patients (HiDenIC-8). We 
selected a population of patients with “suspected sepsis” defined as having blood cultures sent or 
being started on antibiotics within 24 hours of admission to the ICU. We defined demographic, 
clinical and available laboratory variables to include in the clustering algorithm, and selected 
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them on the basis of availability, and absence of redundancy. We used hierarchical clustering to 
evaluate the possible number of clusters according to the data structure, and then ran K-means 
method to determine the actual cluster schedule. Results: We found 13 clusters, 8 of which 
included more than 70 subjects (~2.5% of entire population). We found important differences in 
demographic, clinical and laboratory data at admission, and also, different clinical trajectories in 
terms of patterns of organ dysfunction and mortality. Conclusion: The present study has 
demonstrated that an unsupervised clustering technique based on frequently collected 
demographic, clinical and physiologic data can be used to derive distinct, biologically sound 
clusters of patients who clinically behave differently from each other.     
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1.0  INTRODUCTION 
Sepsis, a syndrome characterized by a systemic, overwhelming response to infection continues to 
be the leading cause of death in the critically ill patient. It is a lethal, incapacitating syndrome, 
which represents an important burden to the health care system, and has become a major health 
care problem.1,2 Importantly, as it usually develops in the hospital, it has largely been under 
recognized as a public health problem in the community3, and currently, worldwide campaigns 
aim to solve that by making the public aware of its existence and its lethality.4   
 
The definition of sepsis has evolved over time, and has done so intimately related to the 
evolution of our own understanding of the syndrome. The term sepsis is attributed to 
Hippocrates, and was used to represent one of the two processes by which biologic material was 
broken down. Indeed Sepsis or “a process by which flesh rots” was associated with bad smell, 
and putrefaction, and considered medically dangerous, whereas Pepsis was a controlled, helpful 
process, analogous to fermentation or digestion.5 Two millennia after the Greco-Roman era, the 
advent and consolidation of the germ theory changed the perspective of the syndrome, attributing 
its consequences to the impact of an external agent (i.e. a bacteria) on the body, and opening new 
therapeutic avenues. However, the germ theory did not fully explain the entire clinical syndrome, 
and it was recognized that the host’s response to infection was a key feature and the potential 
driver of the process. Consequently in 1992, a group of investigators lead by Dr. Roger Bone put 
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together a collection of signs and symptoms to define the “sepsis syndrome” as entry criteria to 
study the effects of methylprednisolone on this devastating condition. This was later defined as 
the Systemic Inflammatory Response Syndrome or SIRS. Thereafter, iterations of these 
consensus conferences have moved forward the definitions of sepsis and categorized the 
different stages or severity of the syndrome. Accordingly today, sepsis complicated with organ 
dysfunction or hypoperfusion was defined as Severe Sepsis, and complicated with hypotension 
refractory to fluid resuscitation, as Septic Shock4. These definitions have been fundamental to 
standardize the language throughout the scientific, clinical and research communities, and has 
allowed to test and implement several diagnostic and therapeutic strategies. However, daily 
practice continues to reveal that in many cases these definitions are still incomplete, too broad, 
and some times even inadequate to predict outcome, but even more importantly, to establish 
specific therapy. This is strongly supported by the fact that to date, and after thousands of 
patients and millions of research dollars spent, there is no one single effective specific treatment 
for sepsis other than the use of antibiotics, fluid and vasopressor resuscitation and organ support 
provided in the intensive care units. Furthermore, it has been recognized in many of these 
“failed” trials that some of these therapies (i.e. Activated protein C), may seem beneficial to 
certain patients, suggesting again that the “one size fits all” approach is far from adequate, that 
there must be important clinical and subclinical differences in how sepsis presents that may open 
avenues to specific treatments and that the approach to investigating Sepsis must change6. This 
construct is supported in the pediatric literature, where differential phenotypes of sepsis have 
been defined and studies are underway to determine whether or not they will serve as primers for 
the use of specific therapies.7 Thus, it is imperative that these different phenotypes are sought, 
found, described and studied, so that treatment strategies can be designed and tailored to 
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populations that will respond to them, and will, for the first time in half a century, impact the 
mortality rate of this lethal, morbid and expensive syndrome.  
 
In accordance with the above, the aim of this study is to determine if there are different patterns 
of sepsis in a large population of septic critically ill patients, and furthermore, whether or not 
these patterns are associated with different patterns of organ involvement and recovery, and with 
patient oriented outcomes. We have designed this study with the assumption that we do not know 
how these phenotypes look like or what defines them. Instead, have used an unsupervised 
clustering analysis approach to retrospectively interrogate a large prospectively collected data 
base, that will allow for natural grouping of patients around specific variables available in this 
database, but also, commonly assessed in any given ICU.  
 
1.1 SIGNIFICANCE 
The majority of the clinical trials conducted in the last twenty years looking for specific therapies 
for sepsis have failed to demonstrate any sustainable benefit on mortality.8 Although there may 
several reasons for this frustrating lack of success, a common feature stands across all of these 
studies. As a result of the preconception that sepsis is indeed one disease, the inclusion criteria of 
these trials has been based mainly on the definition of the sepsis syndrome, and only varying 
according to the severity of the condition. For instance, the PROWESS trial9 randomized patients 
with known or suspected infection, plus three or more signs of systemic inflammation and 
sepsis-induced organ dysfunction of at least one organ or system. In current definitions, these 
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would be patients with severe sepsis. Despite the lack of encouraging results, these trials have 
greatly informed the understanding of the disease. Specifically, most of these trials have 
demonstrated that the effects of different therapeutic strategies are not the same in all patients, 
and that in certain subgroups any given agent may be helpful or harmful.10 This is important 
because it reflects on the fact that perhaps the original conception of sepsis being one disease 
may be insufficient, and that there may be different phenotypes within the syndrome, that will 
respond differently to the same intervention. This is a fundamental step to take as understanding 
whether or not different phenotypes exist will potentially redefine the syndrome, change the pre-
established pathophysiological paradigm and most importantly, will modify our approach to 
treating this deadly condition.  
1.2 SPECIFIC AIMS AND HYPOTHESES 
Our overarching hypothesis is that in a cohort of critically ill patients with “suspected sepsis” 
different clinical phenotypes can be identified based on demographic, clinical, physiologic and 
common laboratory data. We will develop this hypothesis in the setting of the following specific 
aims:  
• Specific Aim 1. To identify naturally occurring phenotypes in a cohort of 
critically ill patients with suspected sepsis using unsupervised clustering analysis.  
o Hypothesis 1.1.  Unsupervised cluster analysis will identify distinct 
phenotypes of patients on the basis of usual demographic, clinical, 
physiologic and laboratory data. 
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• Specific Aim 2. To assess the association of identified clusters with measures of 
patient oriented outcome. 
o Hypothesis 2.1.  There will be differences in 90 day and 1 year mortality 
between clusters. 
o Hypothesis 2.2. There will be differences in hospital and ICU length of 
stay between clusters. 
o Hypothesis 2.3. Clusters will have different patterns of organ/system 
compromise. 
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2.0  METHODS 
The study was conducted in accordance with institutional review board guidelines and approval. 
2.1.1 Source population 
We used The High-Density Intensive Care (HiDenIC-8) database for this study. This dataset 
includes clinical, laboratory and demographic information on 45,655 adult patients admitted to a 
tertiary care institution (Presbyterian University Hospital-UPMC, Pittsburgh, PA), to any of eight 
intensive care units (ICU: cardiac, transplant, neurological, trauma, surgical and medical) in a 
period of eight years (from July 2000 to October 2008). From this dataset, we selected a 
population of patients based on the following inclusion criteria: 1. Age > 18 years; 2. Patients 
admitted to the ICU with criteria for “suspected sepsis”. Suspected sepsis was defined as having 
blood cultures sent or being started on antibiotics within 24 hours of admission to the ICU. We 
used the following exclusion criteria: 1. Patients who developed sepsis or reached the “suspected 
sepsis” criteria beyond 24 hours after admission to the ICU; 2. Patients with ICU length of stay 
of less than 48 hours; 3. Patients who died within the first 48 hours after ICU admission.  The 
cohort selection process and final study population is shown in Figure 1. 
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Figure 1. Consort Diagram                 
 
2.1.2 Data base characteristics, data collection and manipulation of the database 
The HiDenIC-8 database merges information on all patients admitted to the ICU in the period 
from 2000-2008, from several sources including the electronic health record, the Medical 
Archival Repository System (MARS) which contains MARS-MediPAC (demographic, clinical, 
insurance, and diagnostic related group information), MARS-Financial (itemized billing data) 
and MARS-Clinical (laboratory data, International Classification Diseases, 9th edition or ICD-9, 
surgical procedures, and various other elements like reports, clinical notes and discharge 
summaries). All the MARS data was combined with the Eclypsis database which holds all the 
clinical information and the inpatient clinical record. Finally, information from the United States 
Renal Data System (USRDS) and the National Death Index (NDI) was obtained by the honest 
broker and was merged with HiDenIC-8 database before de-identification.  
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In order to optimize the clustering analysis, we selected a cohort of patients that would have all 
the variables of interest. We excluded the patients that did not have a complete set of variables 
for the clustering analysis, obtaining a final cohort of 3315 patients. Comorbidities were 
quantified by calculating the Charlson-Deyo index11,12 as detailed in Appendix A1.   
2.1.3 Hierarchical clustering and variable selection 
The aim of the present study is to identify possible naturally occurring subgroups or phenotypes 
in a large database of patients with suspected sepsis. Clustering analysis is a methodology that 
allows exploring the existence of such natural groups within any given data set. In addition, we 
used an unsupervised approach, in which we allowed the clustering algorithm to determine the 
structure of the data based on the data set and not on pre-specified characteristics. We chose this 
approach because we based our analysis on the assumption that we were oblivious to how these 
clusters should look like, or to how many should there be in the sampled cohort. Although we 
assigned the variables that the model would use for clustering, we were careful to select them on 
the basis of objective criteria. We examined all the non-date variables available in the data set, 
and established redundancy as the primary exclusion criteria for variable selection. Redundancy 
was established through a correlative matrix where significant correlations between variables 
were identified. When present, if biologically plausible, the variables were assumed to carry 
similar information (redundant), and thus, one of the two variables was selected and used in the 
clustering analysis. Eighteen variables were selected using this methodology and are listed in 
table 1.  
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Table 1. Variables used for clustering analysis 
Variables 
Time to sepsis Hemoglobin 
Baseline Creatinine Platelet count 
APACHE III score White blood cell count 
Age Arterial O2 saturation 
Weight Temperature 
Systolic arterial pressure Lactate 
Diastolic arterial pressure Comorbidities 
Mean arterial pressure Transplantation 
Note: All variables used at this stage are variables obtained as first value upon admission to the 
ICU.   
 
We used two methods of clustering. First, we used Hierarchical clustering to determine the 
number of clusters occurring naturally in the dataset. We used clustering around the centroid, 
using the squared Euclidean distance, and then plotted the distance coefficients to identify the 
“step-off” in a scree diagram. A scree diagram or plot is a graphical display of the variance of 
each component in a dataset and is used to define the amount of components that explain the 
majority of the variation in the data. We identified this “step-off” at the observation 3302. The 
number of clusters was defined by the difference between the total number of observations and 
the “step-off”: 3315 - 3302 = 13. We then partitioned the data using the K-means method with 
the number of clusters derived from the Hierarchical clustering analysis (13 clusters).  We 
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determined a threshold “n” below which a cluster would be excluded. Such threshold was 2% of 
the total population, or n = 66.   
2.1.4 Characterization of clusters 
We describe the characteristics of each cluster in three domains: 1. Demographics; 2. 
Clinical/Physiologic data at admission; and 3. Process of care within 24 hours of admission. This 
description will provide the information to inform and develop Specific Aim 1. At a later stage, 
not contained in this manuscript, this information will serve as preliminary data to test these 
phenotypes in a different cohort of patients and determine whether or not these clusters will 
perform in a similar manner in terms of organ dysfunction patterns and mortality.  In addition, 
we will expand the amount of data at ICU admission to biologic markers and microcirculatory 
data to evaluate whether these markers can predict which cluster is most likely to fit each patient. 
Finally, we intend to understand the biology of each cluster in animal models, in order to 
formulate possible subgroups of patients that would benefit from different types of treatment.    
2.1.5 Measures of outcome 
We evaluated the association of each cluster with measures of outcome. Primary endpoints were 
mortality at 90 and 365 days. Secondary outcome measures were ICU and hospital length of 
stay, and organ system involvement at 72 hours and 30 days. We evaluated organ system 
involvement as shown in table 2. One of the objectives of this study was to evaluate if different 
clusters would be associated with different patterns of organ/system involvement, and we 
explored this in a descriptive way. To determine whether or not organ dysfunction was present 
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we assessed each of the variables listed in table 2 according to pre-specified rules based on well 
known organ function assessment scores (Sequential Organ Function Assessment Score or 
SOFA13. These pre-defined rules can be found in Appendix A2. As shown in table 2, each organ 
was assessed by two distinct variables (except for hematologic system). As a general rule, organ 
compromise was confirmed when any one of the variables assessing a specific organ, was found 
to be abnormal in the moderate to severe range. For instance, lactate levels, used to evaluate 
cardiovascular function, were considered altered when values were higher than 2 mmol/L. a mild 
alteration was considered to be a lactate level between 2-3, a moderate 3-4, and a severe 
alteration > 4 mmol/L. Thus the cardiovascular system was said to be dysfunctional when lactate 
levels were above 3 mmol/L in the moderate to severe range. Further information on this 
assignment rule is contained in Appendix A2.   
 
Differences between clusters in categorical or binomial variables were assessed using Pearson’s 
chi2 test. Differences in continuous variables between clusters were assessed using either one-
way analysis of variance (when normal distribution criteria was satisfied), or Kruskal-Wallis 
equality of populations rank test (when absent normal distribution was found). 
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Table 2. Evaluation of organ/system compromise 
Organ/system involved Variable Measured at: 
Cardiovascular Lactate 72 h  
 Use of vasopressors 72 h and 30 days 
Pulmonary PaO2/FiO2 72 h and 30 days 
 Need for mechanical ventilation 72 h and 30 days 
Renal Creatinine 72 h and 30 days 
 Change in Creatinine 72 h and 30 days 
 Need for RRT Within 24 – 72 h and any time 
between 72h and 30 days 
Hematologic Platelet count 72 h and 30 days 
Hepatobiliary INR 72 h and 30 days 
 Total Bilirrubin 72 h and 30 days 
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3.0  RESULTS 
3.1 CLUSTERING ANALYSIS 
3.1.1 Hierarchical clustering, Scree plot and K-means 
The clustering analysis was performed using a two-step approach. First a Hierarchical clustering 
method was used to identify relatively homogeneous groups (clusters) of cases based on the 
selected variables. The Hierarchical clustering analysis and the scree plot suggested the data 
could be divided into 13 clusters as shown in Figure 2.  
 
 
 
 
 
 
 
 14 
 
Figure 2. Scree Plot.  
 
The K-means analysis was ran using these possible 13 clusters and obtained a partitioning of the 
cohort as shown in table 3. However, based on our pre-specified threshold, we excluded clusters 
3 (n=28), 6 (n=2), 8 (n=2), 9 (2), and 10 (37) from the analysis, thus reducing the number of 
effective clusters to 8. Only data on these 8 clusters is reported here forth unless stated otherwise.  
 
Table 3. Results of K-means analysis and summary of the 13 clusters.  
Cluster n Percent (%) Cumulative frequency (%) 
1 413 12.46 12.46 
2 525 15.84 28.30 
3 28 0.84 29.14 
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4 208 6.27 35.41 
5 657 19.82 55.23 
6 2 0.06 55.29 
7 73 2.20 57.50 
8 2 0.06 57.56 
9 2 0.06 57.62 
10 37 1.12 58.73 
11 762 22.99 81.72 
12 417 12.58 94.30 
13 189 5.70 100 
 
 
3.1.2 Description of patient characteristics in the entire cohort  
The analysis was done on a cohort of 3315 patients with “suspected sepsis”. The general 
description of the entire cohort is shown in table 4 below. However, this description is on 3244 
patients given that the patients allocated to clusters 3, 6, 8, 9, and 10 have been excluded.   
 
 
 
 
 
 
Table 3 Continued 
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Table 4. Descriptive statistics of the entire cohort: demographics and admission to ICU data including physiologic, 
risk stratification (APACHE score), DRG classification, and comorbidities.  
Variable Mean Standard 
deviation 
Min Max 
Demographic data  
Age (years) 58.3 16.7 19 106 
Weight (Kg) 83.3 26.9 21 294.8 
Number of Comorbidities 0.96 1.67 0 13 
Gender (n/%) Female  1480 45.6   
Male 1764 54.4 
Number of transplants (kidney 
and/or liver) 
0.10 0.35 0 2 
Clinical/Physiologic  
APACHE III 88.9 14.7 46 148 
SBP (mmHg) 123 30.2 40 263 
DBP (mmHg) 64 19.9 11 202 
MAP (mmHg) 83 21.4 22 215 
Temperature (oC) 36.9 1.5 30 41 
DRG 
(n/%) 
Medical 1678 51.7   
Surgical 1369 42.2   
Missing 197 6.1   
Time to sepsis (minutes)* 251 304 0 1440 
17 
Lactate (n=2117) (mmol/L) 3.5 3.7 0.3 31 
Base deficit (mEq/L) 2.9 6.9 -25 30 
pH 7.35 0.12 6.6 7.69 
PaCO2 (mmHg) 40 13.3 7 167 
PaO2 (mmHg) 141 89.9 19 540 
SaO2 (%) 96 7.7 0 100 
Hemoglobin (mg/dL) 10.9 2.3 3 20.9 
White blood cell count 
(1x109/L) 
13.9 9.3 0.4 106 
Platelet count (1x109/L) 207 122 2 971 
Glucose (mg/dL) 158 70 14 651 
Creatinine (mg/dL) 1.1 0.89 0.1 21 
Process of care 
Vasopressor use** (n/%) 1394 42.9 
Mechanical ventilation** (n/%) 2248 69.3 
RRT ** (n/%) 40 1.2 
FiO2 0.57 0.32 0 1.0 
Fluids administered*** within 
first 24 h (ml) 
4240 2933 3 16382 
RRT=Renal replacement therapy; *=Time from admission to establishment of diagnosis of 
“suspected sepsis”; **=at admission; ***=within first 24 hours after admission; FiO2 = Inspired 
fraction of Oxygen 
Table 4 Continued 
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3.1.3 Description of patient characteristics per cluster 
The analysis of the characteristics of the population in each cluster will be displayed in three 
domains as stipulated in the methods section. These domains will be: 1. Demographics; 2. 
Clinical/Physiologic data at admission; and 3. Process of care within 24 hours of admission. 
Table 5 summarizes these characteristics per cluster, including outcome data.   
 
Table 5. Demographic, clinical/physiologic, process of care and outcome data per cluster 
Variable Cluster 
 1 2 4 5 7 11 12 13 
n 413 525 208 657 73 762 417 189 
Demographic data         
**Age (years) 60.9±17.0 58.4±17.
0 
56.2±14.
7 
60.8±16.
7 
53.4±17.
4 
57.1±16.
2 
56.0±15.
9 
56.9±17.
8 
Weight (Kg) 81±25 82±26 85.6±29.
6 
84.2±26.
6 
80.7±16.
9 
84.7±28.
1 
84.4±28.
0 
79.3±26.
0 
Gender: Females (n/%) 209/50.1 233/44.4 93/44.7 319/48.6 22/30.1 333/43.7 183/43.9 88/46.6 
Mean Charlson-Deyo 
score 
1.0±1.7 0.8±1.5 0.9±1.6 1.2±1.9 0.8±1.7 0.9±1.6 0.9±1.7 0.8±1.4 
Number of transplants 
(kidney and/or liver) 
0.09±0.31 0.06±0.2
6 
0.10±0.3
6 
0.12±0.3
8 
0.06±0.2
8 
0.05±0.2
8 
0.14±0.4
0 
0.13±0.3
9 
Clinical/Physiologic         
**APACHE III 81±11 81±10 102±15 88±14 105±14 90±14 95±13 85±12 
SBP (mmHg) 129±29 130±31 113±28 126±30 112±30 121±28 112±27 120±29 
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DBP (mmHg) 68±18 67±19 57±20 66±19 56±21 64±20 59±20 62±19 
MAP (mmHg) 88±19 88±21 75±21 86±21 75±22 84±21 77±21 81±20 
Temperature (oC) 36.8±2.0 37.2±1.2 36.5±1.3 36.8±1.3 36.4±1.8 36.8±1.4 36.7±1.5 37.2±1.4 
Proportion of patients 
with Temperature < 36oC 
0.07 0.06 0.21 0.11 0.26 0.15 0.17 0.07 
DRG 
(n/%) 
Medical 236/57.2 287/54.7 84/40.4 353/53.7 27/37.0 385/50.5 207/49.6 99/52.4
Surgical 155/37.5 203/38.7 113/54.3 267/40.6 43/58.9 325/42.7 188/45.1 75/39.7
Missing 22/5.3 35/6.6 11/5.2 37/5.6 3/4.1 52/6.8 22/5.3 15/7.9
Time to sepsis (minutes)* 272±306 292±354 245±308 257±294 190±205 227±287 214±266 271±343
Lactate (n=2117) NA NA 5.7±5.11 2.5±2.8 7.3±5.9 3.1±2.8 4.1±3.9 NA 
Base deficit (mEq/L) -0.7±5.4 0.8±5.5 7.9±7.6 1.6±6.7 10.6±8.0 3.1±6.2 5.8±6.8 2.0±5.4 
pH 7.41±0.08 7.39±0.0
8 
7.28±0.1
5 
7.36±0.1
1 
7.26±0.1
5 
7.35±0.1
1 
7.32±0.1
3 
7.38±0.0
9 
PaCO2 (mmHg) 43.2±15.6 40.4±13.
1 
38.0±12.
9 
42.6±14.
3 
34.1±11.
2 
40.5±13.
5 
38.2±11.
0 
38.5±9.7 
PaO2 (mmHg) 121±77 132±78 155±97 135±87 156±86 144±93 151±95 147±81 
SaO2 (%) 97±4 97±5 94±14 95±8 94±13 96±8 96±7 97±6 
Hemoglobin (mg/dL) 11.1±2.2 11.2±2.2 10.9±2.7 11.1±2.2 11.0±3.0 10.8±2.3 10.4±2.4 10.8±2.5 
White blood cell count 
(1x109/L) 
12.7±6.6 13.2±7.2 13.8±9.9 14.9±11.
7 
18.4±18.
21 
13.5±8.3 14.6±9.0 13.7±8.2 
Proportion of patients 
with WBC < 4.5x109/L 
0.06 0.04 0.13 0.05 0.18 0.10 0.11 0.10 
Platelet count (1x109/L) 229±122 232±127 168±110 215±117 174±130 200±123 184±114 202±122
Table 5 Continued 
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Glucose (mg/dL) 161±69 159±64 147±70 155±65 145±107 164±73 154±71 180±77 
Creatinine (mg/dL) 1.2±1.0 1.0±0.81 1.1±0.72 1.2±1.1 1.1±0.9 1.2±0.8 1.1±0.7 1.0±0.4 
Process of care         
Vasopressor use** (n/%) 91/22.0 109/20.8 157/75.5 282/42.9 58/79.5 341/44.8 284/68.1 72/38.1 
Mechanical ventilation 
during first 24 hours 
(n/%) 
177/42.9 296/56.4 184/88.5 474/72.2 70/95.9 571/74.9 355/85.1 121/64.0 
RRT ** (n/%) 3/0.7 0/0 9/4.3 8/1.2 3/4.1 8/1.1 9/2.2 0/0 
FiO2 0.41±0.35 0.46±0.2
8 
0.7±0.3 0.6±0.3 0.64±0.3
3 
0.61±0.3 0.63±0.3 0.48±0.3
1 
Fluids administered 
within first 24 h (L) 
1.1±0.61 3.1±0.62 10.1±1.0 1.9±0.82 13.9±1.2
2 
4.32±0.7
1 
7.0±0.83 5.8±0.94 
Outcome data         
ICULOS (days) 9.06±15.4 8.9±10.1 13.1±14.
4 
11.2±16.
4 
12.2±9.4 12.2±15.
7 
13.3±15.
7 
10.2±13.
9 
HosLOS (days) 19.8±28.1 20.2±18.
4 
21.4±21.
9 
22.1±29.
8 
21.4±18.
4 
23.7±26.
2 
24.5±28.
0 
19.9±20.
7 
Mortality 90 days (n/%) 135/32.7 127/24.2 88/42.3 250/38.1 36/49.3 262/34.4 171/41.0 73/38.6 
Mortality 365 days (n/%) 192/46.5 182/34.7 101/48.6 315/47.9 41/56.2 341/44.8 220/52.8 83/43.9 
RRT=Renal replacement therapy; *=Time from admission to establishment of diagnosis of 
“suspected sepsis”; **=at admission; FiO2 = Inspired fraction of Oxygen 
 
Demographic data. In this section the population will be described in terms of their age, weight, 
and gender distribution per cluster. Overall, the majority of patients were males. In the per 
Table 5 Continued 
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cluster analysis, only cluster No. 1 nominally had slightly more females than males (50.6 vs. 
49.4%). However, this difference was not statistically significant. The clusters were the 
difference between females and males was most notable, were clusters 2 (44.4 vs. 55.6%), 7 
(30.1 vs. 69.9%), 11 (43.7 vs. 56.3%), and 12 (43.9 vs. 56.1%) (Figure 3A).   
 
With regards to age, clusters 1 and 5 had the oldest population with mean age in years of 
60.9±17.1 and 60.9±16.7, respectively. The population age in clusters 4, 7, 11 and 12 had 
significantly different from those in clusters 1 and 5, with 56.2±14.7, 53.4±17.4, 57.1±16.2 and 
55.9±15.9, respectively.   
 
Although statistically, there was a significant difference between clusters in terms of weight 
(p=0.03), it is unlikely that is a relevant one clinically. The group with the heaviest population 
was cluster 4 with mean weight of 85.6±29.5 kg. The cluster with the lightest population was 
cluster 13, with 79.4±26 Kg. Figure 3B shows age and weight per cluster.   
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3A. Gender; 3B. Age and weight. Red and blue continuous lines represent mean age and weight for the 
entire cohort respectively.      
Figure 3. Gender, age and weight per cluster. 
 
 
 
Clinical and physiologic data: There was a significant difference in the distribution of patients 
by diagnosis related group codes (DRG codes) per cluster. The DRG code is a system to classify 
hospital cases into specific groups taking into account International Classification of Diseases 
(ICD) diagnoses, procedures, age, sex, discharge status and presence of complications and 
comorbidities14. These codes are categorized broadly into “service line categories”, namely 
Medical, Surgical or Maternity care. In the studied population, no patients were allocated to the 
“Maternity care” category given that patients with DRG codes related to this group are rarely 
admitted to the hospitals were the HiDenIC-8 database was collected from. As the categories 
denote, overall medical patients are individuals who are suffering from a disease process, and 
have procedures and complications not related to surgical interventions. In opposition, surgical 
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patients are by definition, patients that have required a surgical intervention. This distinction is 
important, as these patients are known to have distinct trajectories in terms of acuity, severity 
and outcome. The selected cohort of patients in the present study showed allocation to one of 
three groups: Medical, Surgical, or Missing data. The number of patients allocated to the 
“Missing data” group was small (n=197/3244, 6.1% of the total population). A total of 1678 
(51.7%) patients were allocated to Medical, and 1369 (42.2%) to the Surgical categories. With 
the exception of clusters 4 and 7, all clusters had more medical than surgical patients as Figure 
4A shows. 
  
Figure 4B, shows the severity of the disease process as quantified by the Acute Physiology, Age, 
Chronic Health Evaluation or APACHE III score15. The APACHE III is a five point scoring 
system (range between 0 and 299), which has been validated and accurately predicts the risk of 
death (area under receiver operating characteristic curve of 0.9) when measured in the first 24 
hours after ICU admission. Overall, APACHE III scores were different between clusters (p = 
0.0001). Clusters 4 and 7 were distinctly higher than the rest, being the only groups with scores 
above 100 (cluster 4, 102±15.2; cluster 7, 105±14.3).   
  
The time in minutes between reaching the criteria for “suspected sepsis” and ICU admission was 
identified as “Time to Sepsis”. Although, overall there was a significant difference between 
clusters, the actual differences were probably not clinically significant. The average Time to 
sepsis for most of the clusters was between 214 and 292 minutes, with the exception of cluster 7, 
which was the shortest with 190 minutes. There was however, important variation as it ranged 
from 0 to 1440 minutes (24 hours). (Figure 4C)    
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4A. Diagnostic Related group classification per cluster. MED = Medical; SURG=Surgical. 4B. APACHE 
III scores per cluster. Red continuous lines represent mean APACHE III score. 4C. Time to diagnosis of sepsis per 
cluster.  Red continuous lines represent mean Time to diagnosis of Sepsis, respectively.   
Figure 4. Diagnostic Related group, APACHE III score and Time to diagnosis of sepsis per cluster.  
 
 
The remainder of the physiologic data will be presented by organ/system.  
Cardiovascular system. The systolic, diastolic and mean arterial pressures are shown in Figure 
5A. The lowest mean arterial pressures (MAP) were found in cluster 7 (74.9±22.7 mmHg), 4 
(75.9±21.4 mmHg) and 12 (76.9±20.5 mmHg), whereas the rest of the clusters had MAP above 
80. Admission lactate was not available for clusters 1, 2, and 13. Of the patients from clusters 
that did have an ICU admission lactate available, most of them were abnormally high (i.e. > 2 
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mmol/L). Cluster 7 had the highest plasma level (7.3±5.9 mmol/L), followed by cluster 4 
(5.7±5.1 mmol/L), and the lowest was seen in cluster 5 (2.5±2.8 mmol/L). Figure 5B shows 
mean±SD lactate concentrations in blood per cluster. In addition, clusters 4, 7 had the highest 
intravenous fluid requirements of the entire cohort (Figure 5C). These two clusters, as well as 
cluster 12 and 13, were all above the cohort average fluid use in the first 24 hours after ICU 
admission of 4.2L. Cluster 1 had the lowest fluid use.   
5A. Systolic, diastolic and mean arterial pressure at admission per cluster. Blue, Green and Red continuous 
lines represent average systolic, mean and diastolic arterial pressure at admission for the entire cohort. 5B. Plasma 
lactate per cluster. P values reported are from either ANOVA or Kruskal-Wallis test depending on normality of 
distribution. 
                           ( Figure 5 continued below )
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5C. Administration of intravenous fluids per cluster in the first 24 hours after ICU admission in mL. Red continuous 
line represents mean fluid administration for the entire cohort in the first 24 hours. 
Respiratory system. From the respiratory standpoint, the clusters appeared to have similar arterial 
blood gases in terms of arterial partial pressure of O2 (PaO2), CO2 (PaCO2) and saturation 
(SaO2). Cluster 1 had the lowest PaO2, and the highest quantitatively were clusters 4, 7 and 12. 
In terms of mean SaO2, interestingly the lowest was found in clusters 4 and 7 (94.0±13.9, 
94.9±13%, respectively). (Figure 6A and B)  
Figure 5. Cardiovascular system variables at admission per cluster.
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6A. Arterial O2 and CO2 partial pressure per cluster. 6B. Arterial saturation of O2 per cluster. P values reported are 
from either ANOVA or Kruskal-Wallis test depending on normality of distribution. 
Figure 6. Respiratory system variables at admission per cluster. 
 
 
Renal system. We used the last recorded Creatinine in the previous year as a measure of baseline 
value. Cluster 5 had the highest baseline Creatinine, followed by cluster 1 (1.24±1.13 and 
1.21±1.03 mg/dL). The rest of the clusters showed mean Creatinine values below 1.2 mg/dL 
(Figure 7A). In terms of acid base balance, clusters 4 and 7 had the lowest pH and highest base 
deficits (BD) (7.26±0.15 vs. 7.28±0.14, and 10.5±7.9 vs. 7.9±7.6 mmol/L, respectively), 
suggesting a metabolic acidosis type of derangement upon admission to the ICU. Clusters 4, 7, 
11 and 12 had BD above the normal upper limit of 2 mmol/L. The clusters 1, 2, 5, and 13 had pH 
and BD within normal limits (Figure 7B and C).     
     
 28 
 
7A. Baseline creatinine per cluster. 7B. pH per cluster. 7C. Base deficit per cluster. Red discontinuous lines 
represent lower and upper limits of normality for pH and Base deficit. Red continuous lines represent mean 
creatinine, pH and base deficit for the entire cohort. 
Figure 7. Renal system variables at admission per cluster.  
 
 
Hematologic system. There were no clinically significant differences in the level of hemoglobin 
at admission to the ICU between clusters (Figure 8A).  No cluster showed mean hemoglobin 
levels below 10 mg/dL. In terms of platelets, all clusters had relatively normal mean counts upon 
admission to the ICU. No cluster was found to have a platelet count below the normal range (150 
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– 400 x 109/L) as shown in Figure 8B. Average platelet count however, was below 200 x 109/L 
in clusters 4, 7 and 12.    
 
8A. Platelet count per cluster. 8B. Hemoglobin concentration in blood per cluster. Red continuous lines 
represent mean platelet and hemoglobin values for the entire cohort. Red discontinuous lines represent range of 
normality. 
Figure 8. Hematologic system variables at admission per cluster.  
 
 
 
Immune and metabolic response. The mean white blood cell count (WBC) on admission for the 
entire population was 13.9±9.3 x 109/L. Cluster 7 had the highest WBC, followed by cluster 5 
and 12 (18.3±18.2, 14.9±11.8, 14.6±8.9 x 109/L, respectively). In terms of temperature at 
admission, the highest mean temperature was found in cluster 13 (37.2±1.4oC), and the lowest in 
cluster 7 (36.4±1.8oC). Figures 9A and B show WBC and temperature at admission per cluster. 
Cluster 7 had the highest proportion of patients with temperature below 36oC, followed by 
clusters 4 and 12 (0.26, 0.21, and 0.17, respectively. Figure 9C).   
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9A. White blood cell count per cluster. 9B. Body temperature at admission to the ICU per cluster. 9C. 
Proportion of patients with body temperature below 36oC at admission per cluster. Red continuous line represents 
mean values for the entire cohort. Red discontinuous lines represent range of normality. 
Figure 9. Immunologic and metabolic response variables at admission per cluster.  
 
 
A Multinomial logistic regression was used to assess which variables better defined each cluster 
(See Appendix B1). Vasopressor use, the need for mechanical ventilation within the first 24 
hours of admission to the ICU and admission temperature were the most important predictors of 
cluster membership according to the multinomial logistic regression coefficient yield. All 
clusters, except for cluster 1 had platelet count and APACHE III score as a predictor of 
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membership. Baseline creatinine was an important predictor of membership only in clusters 1 
and 5. Age, was an important predictor of membership in clusters 4, 7, 11 and 12. Finally, WBC 
was a predictor of membership only in clusters 5, 7 and 12.   
  
3.2 ASSOCIATION OF CLUSTERS WITH OUTCOME MEASURES 
3.2.1 Association with mortality and length of stay 
Both mortality at 90 and 365 days were different between clusters as demonstrated in Figure 
10A. The highest 90-day mortality was found in cluster 7, followed by 4 and 12 (0.49, 0.42 and 
0.41, respectively). These same three clusters had the highest 365-day mortality, with cluster 7 
being the highest (0.56). However, 365-day mortality was higher in cluster 12 than in cluster 4 
despite (0.52, 0.48, respectively) cluster 4 having a higher 90-day mortality. 
 
Intensive care unit (ICULOS) and hospital length of stay (HosLOS) per cluster were also 
studied. Mean ICULOS and HosLOS were 11.2±14.8 and 22.0±25.7 days, respectively. Four 
clusters were above the mean ICU LOS for the entire cohort, with cluster 12 having the longest 
mean stay, followed by 4, 11 and 7 (13.3±15.7, 13.1±14.4, 12.3±15.7, 12.1±9.4, respectively). 
Only two clusters, 12 and 11, had HosLOS beyond the cohort mean (24.5±27.9 and 23.7±26.2, 
respectively).(Figure 10B)  
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10A. Ninety day and 1 year mortality per cluster. 10B. ICU and hospital length of stay per cluster. 
Continuous black line represents mean 90-day and ICULOS for the entire population. Gray discontinuous line 
represents mean 1-year and Hospital LOS for the entire cohort. 
Figure 10. Mortality and hospital and ICU length of stay per cluster.  
3.2.2 Association with organ dysfunction and patterns of organ/system compromise 
The association of each cluster with organ dysfunction was also explored. Organ/system 
dysfunction was assessed as shown in table 2 at two different time points: 72 hours and 30 days. 
Based on the pre-specified decision rules (Appendix A2), the number of organs, the pattern of 
organ compromise and the trajectory of each cluster in terms of clinical course were determined. 
The number of organs compromised, and the pattern of involvement per cluster for the 72-hour 
and 30 day time points are shown in Table 6 and 7, respectively. The most frequently 
compromised organs/systems were the Cardiovascular (6 clusters), Respiratory (5 clusters), and 
Hepatobiliary systems (5 clusters). The renal and Hematologic systems were compromised in 3 
clusters. Only cluster 2 had no organ compromise at 72 hours. Clusters 1 and 13 had 1 organ 
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compromised; cluster 5 had 2 organs; cluster 11, 3 organs; and finally, clusters 4, 7, and 12 had 5 
organs compromised. Results will be presented below according to each organ/system assessed.  
 
Table 6. Organ compromise at 72 hours per cluster 
 Clusters 
Organ/system 1 2 4 5 7 11 12 13 
Cardiovascular Yes No Yes# Yes Yes# Yes Yes# No 
Lactate (mmol/L)* 3.1 + 2.4 - 4.6 + 2.0 - 5.5 + 2.3 - 3.1 + 1.9 - 
Vasopressor use - - + + + + + - 
Pulmonary No No Yes Yes Yes Yes Yes No 
MV - - + + + + + - 
PaO2/FiO2  222 - 217 - 203 - 206 - 208 - 218 - 228 - 216 - 
Renal No No Yes No Yes# No Yes No 
Δ in Cr (mg/dL)* 0.4/R - 0.2/0 - 0.7/R - 0.6/R - 1/I + 
0.4/
R 
- 0.5/R - 
0.3/
R 
- 
RRT - - + - + - + - 
Hematologic No No Yes# No Yes# No Yes# No 
Δ Platelet count* 
(x103/L)  
-17 - -30 - -60 + -38 - -99 + -43 - -58 + -30 - 
Hepatobiliary No No Yes# No Yes# Yes Yes# Yes# 
Total Bilirrubin 
(median, mg/dL)* 
0.9 - 1.3 - 4.3 + 1.6 - 4.8 + 2.4 + 4.2 + 3.8 + 
INR 1.4 - 1.3 - 1.6 + 1.4 - 1.7 + 1.4 - 1.6 + 1.5 + 
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Total of organs 1 0 5 2 5 3 5 1 
Compromise with 
criteria in 
“severe” range 
CV, R, 
Hm 
CV,R,H
m, Hp 
CV, Hm, 
Hp 
Hp 
*=Value of each variable | assignment (if organ dysfunction criteria reached then “+”; if not, then 
“–“). # = Reached organ dysfunction criteria with values denoting severe compromise.  Shaded 
gray area represents organ dysfunction criteria. Yes/No denomination = “Yes”, was assigned if 
organ dysfunction criteria was reached for the system in question for each cluster. “No”, was 
assigned if it did not.  
Table 7 shows the breakdown for each organ/system per cluster at the 30-day time point.  
Table 7. Organ compromise at 30 days per cluster 
Clusters 
Organ/system 1 2 4 5 7 11 12 13 
Cardiovascular No No No No Yes No Yes No 
Vasopressor use - - - - + + + - 
Pulmonary No No Yes Yes Yes Yes Yes Yes 
MV - - + + + + + + 
PaO2/FiO2*  284 - 257 - 177 + 179 + 196 + 239 - 255 - 157 + 
Renal No No Yes Yes Yes No Yes Yes 
Δ in Cr (mg/dL / 
RIFLE category) * 
0.3/R + 
0.04/
0 
- 
0.35/
R 
+ 0.35/R + 
0.42
/I 
+ 
0.23
/R 
- 
0.25/
R 
- 
0.48
/R 
+ 
Table 6 Continued 
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RRT - - + + + - + + 
Hematologic No No No No No No No No 
Platelet count 
(x109/L) *  
225 - 206 - 228 - 236 - 248 - 218 - 178 - 165 - 
Hepatobiliary No No No No Yes No Yes Yes 
Total Bilirrubin 
(median, mg/dL) * 
1.0 - 1.9 - 1.9 - 1.6 - 14.4 + 1.4 - 3.9 + 12 + 
Total of organs 0 0 2 2 4 1 4 3 
*=Value of each variable | assignment (if organ dysfunction criteria reached then “+”; if 
not, then “–“). RIFLE category: 0=Normal; R=Risk, I=Injury. Shaded gray area represents organ 
dysfunction criteria. Yes/No denomination = “Yes”, was assigned if organ dysfunction criteria 
was reached for the system in question for each cluster. “No”, was assigned if it did not. 
 
 
Cardiovascular system: Lactate was selected as global measure of organ perfusion and thus of 
cardiovascular sufficiency. Average lactate levels at 72 hours for the entire cohort was 2.9±3.3 
mmol/L (normal values < 2 mmol/L). Patients in Cluster 7 had significantly elevated lactate 
levels after 72 hours of admission to the ICU, and registered as the highest levels of the entire 
cohort, followed by Cluster 4 (5.5±5.2 and 4.6±5.0 mmol/L, respectively; See Figure 11A). The 
lowest 72 hour mean lactate level was found in cluster 13, which was normal, followed closely 
by clusters 5 and 2 (1.9±1.7, 2.0±1.8, 2.4±2.6 mmol/L respectively).  
 
Table 7 Continued 
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The need for vasopressors was explored also as a measure of cardiovascular compromise and 
was quantified as either being on or off any vasopressor or inotrope at 72 hours and at 30 days 
after ICU admission. Clusters 7, 4 and 12 had the highest proportion of patients requiring 
vasopressors or inotropes in the first 72 hours after ICU admission as shown in Figure 11B (0.45, 
0.44 and 0.43). The lowest requirement of cardiovascular support was seen in clusters 2 and 1 
(0.14 and 0.17). At 30 days the proportion of patients on vasopressor or inotropic support 
decreased 5-10 fold in every cluster as expected (Figure 11B). The pattern persisted though, with 
clusters 7 and 12 showing the highest requirement of pharmacologic cardiovascular support 
(0.06 and 0.05, respectively). However, cluster 4 showed a decrease in the proportion of patients 
on vasopressors or inotropes at this time point. 
 
 
11A. Blood lactate at 72 hours per cluster. Black continuous line represents mean lactate concentration for 
the entire population. Black discontinuous line represents upper limit of normality. 11B. Proportion of patients 
requiring vasopressor use at 72 hours and 30 days after admission to the ICU. P values for proportions derived from 
logistic regression. 
Figure 11. Cardiovascular system variables at 72 hours and 30 days per cluster.  
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Respiratory system: The proportion of patients requiring mechanical ventilation in the entire 
cohort at 72 hours was 48.6%. Clusters 7, 4 and 12 had the highest proportion of patients 
requiring mechanical ventilation at 72 hours (0.69, 0.63 and 0.58, respectively). As expected, 
only 6.4% of the entire population required mechanical ventilator support at 30 days. However, 
the pattern persisted, with clusters 7, 4 and 12 having the highest proportion of ventilator 
dependent patients (see Figure 12A).  
 
The ratio between the partial pressure of O2 and the delivered fraction of O2 (PaO2/FiO2 ratio) 
was also calculated to assess the extent of pulmonary compromise. Although all these patients 
did not have acute respiratory distress syndrome, we used the Berlin definition16 to gauge and 
classify the extent of the oxygenation compromise according to the PaO2/FiO2 ratio like this: 
• Mild:         PaO2/FiO2 ratio between 200-300 
• Moderate:  PaO2/FiO2 ratio between 100-200 
• Severe:       PaO2/FiO2 ratio below     100 
 
At 72 hours, the mean PaO2/FiO2 ratio for the entire cohort was 216±125 (n=580 observations), 
and at 30 days 226±146 (n=95 observations). Cluster 12, followed by 11 and 1 had the highest 
PaO2/FiO2 ratios at 72 hours, whereas 4,5 and 7 had the lowest. Similarly, clusters 1, 2, 11 and 
12, had the highest PaO2/FiO2 ratios at 30 days, while 4, 5, 7 and 13 had the lowest as shown in 
Figure 12B.  
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12A. Proportion of patients requiring mechanical ventilator support at 72 hours and 30 days after ICU 
admission. 12B. PaO2/FiO2 ratio at 72 hours and 30 days after ICU admission. Black continuous line represents 
mean values for the entire cohort at 72 hours. Gray discontinuous line represents mean values for the entire cohort at 
30 days. P values for proportions derived from logistic regression. 
Figure 12. Respiratory system variables at 72 hours and 30 days per cluster.  
 
 
Renal system: Renal function and compromise was assessed by measuring creatinine at baseline, 
72 hours and 30 days, by assessing the change in Creatinine from baseline to the pre-specified 
timepoints, and by assessing the need of renal replacement therapy (RRT) at 72 hours and 30 
days. Figure 13A shows the levels of Creatinine at baseline, and 72 hours and 30 days after 
admission to the ICU. Mean baseline, 72 hour and 30 day creatinine levels for the entire cohort 
were 1.10±0.89, 1.59±1.33 and 1.48±1.22 mg/dL, respectively. Baseline creatinine values were 
significantly different between clusters (p=0.0001), with clusters 5 and 1 having the highest 
variability. However, mean values were rather similar, and differences were not clinically 
significant. More important to evaluate the impact of sepsis on renal function was the change in 
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creatinine, shown in Figure 13B. Clusters 7, 4 and 5 had the largest creatinine increase at 72 
hours. The RIFLE classification of acute kidney injury17 has been extensively validated, and is 
pertinent as it is associated with adverse renal outcomes such as dialysis, non-recovery of renal 
function and death. These instrument classifies the renal injury in progressive categories as R 
(Risk), I (Injury), F (Failure), L (Loss) and E (End stage kidney disease). It is based on serum 
creatinine and urine output. In this study, only the creatinine criterion was explored. The RIFLE 
system classifies an acute rise in creatinine of 0.3 mg/dL as R, or being “at risk” for AKI. An 
increment in creatinine that doubles baseline values is considered as I, or Injury. At 72 hours, all 
clusters except cluster 2 had criteria for RIFLE R classification. However, cluster 7 showed 
almost doubling of creatinine levels at this time point, suggesting these patients were more 
severely compromised from the renal stand point (increase in creatinine 1.93 times the mean 
baseline for the cluster). In addition, cluster 4’s mean baseline creatinine increased 1.7 times, 
suggesting as well higher level of renal compromise. At 30 days, cluster 7 had the highest change 
from baseline (1.7 times), followed by cluster 13 (1.5 times).  All other clusters showed 
increments in creatinine below 1.5 times the baseline suggesting renal recovery.  
 
13A. Serum Creatinine baseline (black), at 72 hours (white) and at 30 days (gray) after ICU admission. 
Continuous black lines represent mean baseline creatinine value for the entire population. Discontinuous black and 
gray lines represent mean creatinine values for 72 hour and 30 day timepoint for the entire cohort, respectively. 13B. 
Change in creatinine calculated as creatinine level at 72 hours (black bars) or 30 days (gray bars) after ICU 
admission minus baseline creatinine. Black continuous bar represents mean creatinine change at 72 hours for the 
entire cohort. Gray discontinuous line represents mean creatinine change at 30 days for the entire cohort. 13C. 
Percentage of patients per cluster requiring RRT within the first 72 hours of admission to the ICU (black bars), and 
between 72 hours and 30 days (gray bars). 
Figure 13. Renal system variables at 72 hours and 30 days per cluster. 
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The need for RRT was also explored as a measure of renal compromise. Figure 13C shows the 
proportion of patients requiring RRT at 72 hours and then at any time after 72 hours. Clusters 4, 
12 and 7 had the highest percentage of patients requiring RRT at 72 hours (25, 15.3, and 15.1%, 
respectively). As expected, clusters 4, 7 and 12 had the highest requirement of RRT beyond 72 
hours. Of these clusters, the only cluster that did not show improvement (i.e. a decrease in % of 
patients on RRT beyond 72 hours) was cluster 7. Importantly, clusters 2 and 13 had a doubling 
of the need for RRT when the 72 hours time point is compared to beyond 72 hours.  
Hematologic system. Platelet count was the mainstay of the assessment. Admission (baseline), 
72 hour and 30 day platelet counts for the entire cohort were 207±122, 167±110 and 214±141, 
respectively. Figure 14A shows baseline, 72 hour and 30 day platelet counts per cluster. Severity 
of compromise was related to platelet count drop after admission to the ICU, and it was 
quantified as the change in platelets from baseline to 72 hours, as shown in Figure 14B. In 
general, all clusters showed an average decline in platelet count of -41±73x109/L. Cluster 7, 4 
and 12 displayed the largest decline in platelet count (-99, -60 and -58 x109/L). Only cluster 7 
reached a mean platelet count below 100 x 109/L.    
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14A. Platelet count at admission (baseline), 72 hours and 30 days after admission to the ICU. 14B. Change 
in platelet count calculated as Platelet count at 72 hours minus baseline platelet count. Black continuous line 
represents mean change in platelet count for the entire cohort. 
Figure 14. Hematologic system variables at 72 hours and 30 days per cluster. 
Hepatobiliary system. Total bilirubin levels and the International Normalized Ratio or INR were 
used to assess hepatic compromise. Total bilirubin at 72 hours and 30 days was elevated for the 
entire cohort, suggesting high incidence of hepatic compromise in this population (5.3±7.3 and 
7.3±10.4 mg/dL). Of note, for all clusters total bilirubin levels at 30 days were higher than at 72 
hours. Clusters 7, 4 and 12 presented the highest total bilirubin levels at 72 hours. In addition to 
these same clusters, cluster 13 presented the highest total bilirubin levels at 30 days (Figure 
15A).  
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International Normalized Ratios did not differ much between 72 hours and 30 days, with mean 
values of 1.49±0.6 and 1.52±0.70, respectively. There were significant differences in the by 
cluster analysis, with cluster 7, 4 and 12 having the highest levels at 72 hours, and 7 and 13 at 30 
days (Figure 15B)  
15A. Total bilirubin levels at 72 hours and 30 days per cluster. Black continuous line represents mean total 
bilirubin at 72 hours for the entire cohort. Gray discontinuous line represents mean total bilirubin at 30 days for the 
entire cohort. 15B. INR at 72 hours and 30 days per cluster. 
Figure 15. Hepatobiliary system variables at 72 hours and 30 days per cluster. 
When comparing the trajectory of organ compromise from 72 hours to 30 days, the results 
showed that almost all clusters (with exception of cluster 7 and 12), had resolution of the 
cardiovascular compromise. Both clusters 7 and 12 however, remained dependent on 
vasopressors.  
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From a respiratory stand point, all clusters that showed pulmonary dysfunction at 72 hours, 
where still ventilator dependent at 30 days, which suggests not only real dysfunction, but 
inability to recuperate. Cluster 13 had an increase in ventilator use above average at 30 days 
despite not having it at 72 hours, which may suggest complications during hospital stay affecting 
the respiratory system, which are not uncommon.  
 
Interestingly, one month after admission, patients in clusters characterized by significant 
increments in creatinine from baseline, although regressing, where still in average about 0.26 
mg/dL from baseline, with clusters 4, 5, 7, and 13 being even above 0.3 mg/dL. The percentage 
of patients requiring RRT between 72 hours of admission and 30 days was slightly higher than 
the percentage within the first 72 hours. Importantly, cluster 13 showed a marked rise in RRT 
need at 30 days, probably alluding to complications of critical illness given that at 72 hours the 
proportion of patients needing RRT was 3 times less.  
 
All patients with hematological alterations given by platelet count drop recovered by 30 days, 
suggesting this is a marker of acute disease. No cluster at 30 days had a mean platelet count 
below 200 x 109/L. Finally, only clusters 4 and 11 showed recovery of the hepatobiliary system 
as measured by total bilirubin levels. 
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3.2.3 Patterns of organ/system compromise 
Based on the pre-specified decision rules (Appendix A2), the number of organs, the pattern of 
organ compromise and the trajectory of each cluster in terms of clinical course were determined. 
Table 6 shows the summary of the number of organs compromised, and the pattern of 
involvement per cluster for the 72-hour time point. The most frequently compromised 
organs/systems were the Cardiovascular (6 clusters), Respiratory (5 clusters), and Hepatobiliary 
systems (5 clusters). The renal and Hematologic systems were compromised in 3 clusters. Only 
cluster 2 had no organ compromise at 72 hours. Clusters 1 and 13 had 1 organ compromised; 
cluster 5 had 2 organs; cluster 11, 3 organs; and finally, clusters 4, 7, and 12 had 5 organs 
compromised. 
 
Although clinically multisystem organ failure is defined by compromise of two or more 
organ/systems4, patients with two compromised organs had more similarities with those with one 
organ dysfunction, than patients who had 3 or more. Thus, a comparison between clusters 
characterized by 1-2 and those with 3 or more organ/system dysfunctions was done. Table 8 
shows the summary of all demographic, clinical, process of care and outcome variables 
compared between clusters with 1-2 organ dysfunctions vs. those with >=3.  
 
Not surprisingly, APACHE III score, ICULOS, HosLOS and mortality at 90 and 365 days are 
different between these two sets of clusters, with those associated with 3 or more dysfunctional 
organs having higher scores, stay and mortality, respectively as shown in table 8. In terms of 
demographic data, clusters with 1-2 organ dysfunctions had more females, more comorbidities 
and less number of transplants. 
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Table 8. Demographic, clinical/physiologic, process of care and outcome data per cluster  
 Groups by number of compromised organs 
 1 – 2  ≥3  
Clusters 1 5 13 Mean 4 7 11 12 Mean p 
n 413 657 189  208 73 762 417   
Demographic data           
Age (years) 60.9±17.0 60.8±16.7 56.9±17.8 60.3±17 56.2±14.7 53.4±17.4 57.1±16.2 56.0±15.9 56.5±16 0.00001 
Weight (Kg) 81±25 84.2±26.6 79.3±26.0 82.3±26.0 85.6±29.6 80.7±16.9 84.7±28.1 84.4±28.0 84.5±27.8 0.049 
Gender: Females 
(n/%) 
209/50.1 319/48.6 88/46.6 616/49.0 93/44.7 22/30.1 333/43.7 183/43.9 631/43.2 0.003 
Mean Charlson-
Deyo score 
1.0±1.7 1.2±1.9 0.8±1.4 1.1±1.8 0.9±1.6 0.8±1.7 0.9±1.6 0.9±1.7 0.9±1.6 0.025 
Number of 
transplants (kidney 
and/or liver) 
0.09±0.31 0.12±0.38 0.13±0.39 0.096±3.34 0.10±0.36 0.06±0.28 0.05±0.28 0.14±0.40 0.12±0.38 0.049 
Clinical/Physiologic           
APACHE III 81±11 88±14 85±12 85±13 102±15 105±14 90±14 95±13 94.4 0.0001 
SBP (mmHg) 129±29 126±30 120±29 126±30 113±28 112±30 121±28 112±27 117±29 0.0001 
DBP (mmHg) 68±18 66±19 62±19 66±20 57±20 56±21 64±20 59±20 61±20 0.0001 
MAP (mmHg) 88±19 86±21 81±20 86±20 75±21 75±22 84±21 77±21 80±21 0.0001 
Temperature (oC) 36.8±2.0 36.8±1.3 37.2±1.4 36.9±1.5 36.5±1.3 36.4±1.8 36.8±1.4 36.7±1.5 36.7±1.2 0.0001 
Proportion of 
patients with 
Temperature < 36oC 
0.07 0.11 0.07 0.08±0.02 0.21 0.26 0.15 0.17 0.19±0.05 0.009 
DRG 
(n/%) 
Medical 22/73.3 44/62.0 7/53.8 687/54.6 23/53.5 6/31.6 69/59.0 39/54.2 703/48.2  
0.003 Surgical 7/23.3 25/35.2 3/23.1 497/39.5 19/44.2 11/57.9 37/31.6 28/38.9 669/45.8 
Missing 1/3.4 2/2.8 3/23.1 74/5.9 1/2.3 2/10.5 11/9.4 5/6.9 88/6 
Time to sepsis 
(minutes)* 
272±306 257±294 271±343 264±306 245±308 190±205 227±287 214±266 224±280 0.0001 
Lactate (mmol/L) NA 2.5±2.8 NA 2.5±2.8 5.7±5.11 7.3±5.9 3.1±2.8 4.1±3.9 3.9±3.9 NA 
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Base deficit (mEq/L) -0.7±5.4 1.6±6.7 2.0±5.4 1.0±6.3 7.9±7.6 10.6±8.0 3.1±6.2 5.8±6.8 5.0±7.0 0.0001 
pH 7.41±0.08 7.36±0.11 7.38±0.09 7.37±0.12 7.28±0.15 7.26±0.15 7.35±0.11 7.32±0.13 7.32±0.13 0.0001 
PaCO2 (mmHg) 43.2±15.6 42.6±14.3 38.5±9.7 42.4±14.2 38.0±12.9 34.1±11.2 40.5±13.5 38.2±11.0 39.1±12.7 0.0001 
PaO2 (mmHg) 121±77 135±87 147±81 133±85 155±97 156±86 144±93 151±95 149±94 0.003 
SaO2 (%) 97±4 95±8 97±6 96±6.5 94±14 94±13 96±8 96±7 95±9 0.02 
Hemoglobin 
(mg/dL) 
11.1±2.2 11.1±2.2 10.8±2.5 11.0±2.3 10.9±2.7 11.0±3.0 10.8±2.3 10.4±2.4 10.7±2.4 0.001 
White blood cell 
count (1x109/L) 
12.7±6.6 14.9±11.7 13.7±8.2 13.9±8.0 13.8±9.9 18.4±18.21 13.5±8.3 14.6±9.0 14.1±9.5 0.01 
Proportion of 
patients with WBC 
< 4.5x109/L 
0.06 0.05 0.10 0.07±0.03 0.13 0.18 0.10 0.11 0.13±0.04 0.054 
Platelet count 
(1x109/L) 
229±122 215±117 202±122 218±120 168±110 174±130 200±123 184±114 190±120 0.0001 
Glucose (mg/dL) 161±69 155±65 180±77 160±68 147±70 145±107 164±73 154±71 157±73 0.24 
Creatinine (mg/dL) 1.2±1.0 1.2±1.1 1.0±0.4 1.2±1.0 1.1±0.72 1.1±0.9 1.2±0.8 1.1±0.7 1.1±0.8 0.35 
Process of care           
Vasopressor use** 
(n/%) 
91/22.0 282/42.9 72/38.1 0.34±0.11 157/75.5 58/79.5 341/44.8 284/68.1 0.67±0.15 0.023 
Mechanical 
ventilation during 
first 24 hours** 
(n/%) 
177/42.9 474/72.2 121/64.0 771/61.3 184/88.5 70/95.9 571/74.9 355/85.1 1180/80.8 0.00001 
RRT ** (n/%) 3/0.7 8/1.2 0/0 11/5.8 9/4.3 3/4.1 8/1.1 9/2.2 29/8.4 0.28 
FiO2 0.41±0.35 0.6±0.3 0.48±0.31 0.54±0.33 0.7±0.3 0.64±0.33 0.61±0.3 0.63±0.3 0.63±0.31 0.0001 
Fluids 
administered*** 
within first 24 h (L) 
1.1±0.61 1.9±0.82 5.8±0.94 2.2±1.7 10.1±1.0 13.9±1.22 4.32±0.71 7.0±0.83 6.4±2.8 0.0001 
Outcome data           
ICULOS (days) 9.06±15.4 11.2±16.4 10.2±13.9 10.4±15.7 13.1±14.4 12.2±9.4 12.2±15.7 13.3±15.7 12.7±15.3 0.0001 
Table 8 Continued 
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HosLOS (days) 19.8±28.1 22.1±29.8 19.9±20.7 21.0±28.0 21.4±21.9 21.4±18.4 23.7±26.2 24.5±28.0 23.5±25.8 0.016 
Mortality 90 days  
(n/%) 
135/32.7 250/38.1 73/38.6 0.36±0.48 88/42.3 36/49.3 262/34.4 171/41.0 0.38±0.49 0.33 
Mortality 365 days 
(n/%) 
192/46.5 315/47.9 83/43.9 0.47±0.50 101/48.6 41/56.2 341/44.8 220/52.8 0.48±0.50 0.49 
RRT=Renal replacement therapy; *=Time from admission to establishment of diagnosis of 
“suspected sepsis”; **=at admission. 
 
From a clinical/physiologic standpoint, there were statistical but not clinical differences in 
systolic, diastolic and mean arterial pressure, although the percentage of patients requiring 
vasopressor support within the first 24 hours of admission in clusters with 3 or more 
dysfunctional organs was twice that of clusters with 1-2 compromised organs. There were clear 
acid base derangements, with higher base deficits in those with more organs compromised, with 
normal levels of PaCO2, suggesting important metabolic alterations. The proportion of patients 
with leukopenia (WBC < 4.5 x103/L) were almost twice as much in the group of clusters with 3 
or more dysfunctional organs than in those with 1-2 organs, suggesting important derangements 
in the immune response. (Figure 16A) In addition, the proportion of patients with hypothermia 
(defined at temperatures below 36oC) was more twice as high in the patients with more organs 
compromised than those with less, again pointing to the observation that these patients may 
indeed have an alteration in their immune and metabolic response to infection. (Figure 16B) 
Finally, patients with more organs compromised had lower levels of platelets and a deeper 
decrement as compared to those with less compromised organs, suggesting perhaps a more 
important role of coagulation-inflammatory interactions in these patients. From a process of care 
stand point, patients with more organ dysfunction had more need for mechanical ventilation and 
Table 8 Continued 
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RRT within first 24 hours of admission to the ICU, and required higher amounts of fluid 
resuscitation as compared to those with less organ dysfunction.      
 
 
16A. Proportion of patients with admission WBC below 4.5x106/L per cluster. 16B. Proportion of patients 
with admission temperature below 36oC per cluster. Black continuous lines represent average proportion of patients 
for the entire population in each case. 
Figure 16. Proportion of patients with leukopenia and hypothermia at ICU admission per cluster. 
 
 
3.2.3.1 Comparison of clusters characterized by renal, hematologic and hepatobiliary 
compromise  
 
Clusters 4, 7 and 12 had renal, hematologic and hepatobiliary compromise in addition to 
cardiovascular and respiratory (group “All”). Clusters 11 and 13 on the other hand had 
hepatobiliary compromise but not renal or hematologic (group “Hep”). Finally, 1, 2 and 5 had no 
50 
renal, hematologic or hepatobiliary compromise (groups “None”). Admission characteristics 
were compared between these three groups and is shown below in table 9: 
Table 9. Descriptive statistics of demographics and admission data stratified by pattern of organ compromise 
in three groups: All, Hep and None. 
Variable All Hep None P 
(ANOVA) 
Clusters 4, 7, 12 11, 13 1, 2, 5 NA 
Age (years) 55.7±15.7 57.1±16.2 59.8±17.0 0.0001 
Weight (Kg) 84.4±27.6 84.7±28.1 82.2±26.2 0.053 
Number of Comorbidities 0.9±1.7 0.9±1.6 1.0±1.7 0.29 
Number of transplants (kidney 
and/or liver) 
0.1±0.4 0.1±0.4 0.1±0.3 0.001 
APACHE III 98±14 90±14 84±13 0.0001 
MAP (mmHg) 76±20 83±21 86±20 0.0001 
Temperature (oC) 36.6±1.5 36.8±1.4 37.0±1.5 0.0001 
Lactate (mmol/L) 4.9±4.6 3.0±2.8 2.6±2.8 0.0001 
Base deficit (mEq/L) 6.9±7.3 3.1±6.2 1.0±6.1 0.0001 
White blood cell count (1x109/L) 14.8±10.6 13.5±8.3 13.8±9.2 0.02 
Platelet count 
(1x109/L) 
178±115 200±123 222±122 0.0001 
Creatinine (mg/dL) 1.1±0.7 1.2±0.8 1.1±1.0 0.63 
Fluids administered within first 
24 h (mL) 
8638±2467 4320±714 2485±1547 0.0001 
(See text for further explanation) 
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The table shows groups based on compromise of renal, hematologic and hepatobiliary 
compromise (All); only hepatobiliary compromise (Hep); or no compromise of renal, 
hematologic or hepatobiliary systems (None), aside from cardiovascular and respiratory. 
Patients with renal, hematologic and hepatic compromise were younger and had higher 
APACHE III admission scores. In addition, they had lower admission MAP and temperature, and 
had metabolic acidosis whereas base deficit for Hep and None was within normal limits. Patients 
in the “All” group had higher WBC counts than patients in the “Hep” group, but not more than 
those in the “None” group (Bonferroni). As expected, platelet count was lower in the “All” group 
as compared to patients in the other groups. However, baseline creatinine was not different 
between groups. Finally, there were important differences in fluids administered, with higher 
volumes in the All group, vs. Hep and None.    
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4.0  DISCUSSION 
The aim of the present study was to interrogate a prospectively collected database of critically ill 
patients selected on the basis of having “suspected sepsis” and evaluate if distinct, clinically 
sound groups of patients could be found. In doing so, we used clustering analysis which is “the 
grouping of individuals in a population in order to discover structure in the data”18. Given that 
this study was based on the presumption that the characteristics of such “clusters” of patients if 
they exist, are completely unknown to us, we selected a method that would allow the data 
structure to define such the associations between patients. We did this in a two-step approach. 
First we interrogated the data to find out the amount of “partitions” or clusters this particular data 
set would have by using Hierarchical clustering. This is the most commonly used method to 
explore structure in any given data set. It is based on deriving clustering from a given 
dissimilarity matrix. The dissimilarity between observations (or patients), can be then used to 
create a Scree plot, and derive from it the number of clusters this particular data set should 
contain. The second step was to run a K-means algorithm. The aim of the K-means is to partition 
the data in “k” clusters, so that the within-group sum of squares is minimized. This “k” number 
of clusters was derived from the Hierarchical cluster analysis. Thus, the investigators had no 
input on how many clusters should be found, or how the data should be partitioned.  This is a 
simple method that provides objectivity to the derivation of the clusters.  
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The only intervention where the investigators had input in defining this specific partition of the 
data came into play when selecting the variables that would fit the hierarchical clustering model. 
We also tried to objectify this step. We selected the variables by 1. Availability in our data set; 
and 2. Whether or not it would be feasible to easily collect on admission to the ICU. Then, we 
ran a correlative matix of all the variables, and found those, which would correlate to each other. 
If correlation was found, in the setting of biological plausibility, only one of the two variables 
was selected. Selection between the two was made on the basis of availability in the data (i.e. the 
variable that was more available in the entire population).  
 
Although any clustering method will yield some sort of partition of the data, regardless of 
whether it makes sense, we evaluated the obtained clusters for biological plausibility and clinical 
sense. We found these patients were indeed similar to each other around their clinical 
characteristics at ICU admission, and thus accepted these groups as valid. The clinical 
trajectories of the patients suggested later on that clusters could perhaps be further grouped into 
larger groups. For instance, clusters 4, 7, and 12 were similar between each other, as were 1, 5, 
and 13. Cluster 11, was sort of in between these two clusters, sharing characteristics of both in 
different variables, and finally, cluster 2 was definitively different, showing those patients who 
never had organ compromise at 72 hours or 30 days. In addition, we found that different 
variables were of different importance when defining cluster membership depending of the 
cluster. Appendix B1 shows the multinomial logistic regression for cluster membership as well 
as the coefficients of each variable. These coefficients provide information as to how important 
each variable in the model is to determine cluster membership. These coefficients represent the 
impact of the change of 1 unit of the specific variable, in increasing or decreasing (- sign) the 
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odds of being part of that specific cluster. For example, in the output for cluster 1, the variable 
with the second largest effect to define membership to cluster 1 was baseline creatinine, with a 
coefficient of 0.25. This means that for every 1 unit increase in baseline creatinine, the odds of 
being a member of cluster 1 increase by 0.25. In other words, the higher the patient’s creatinine, 
the higher the likelihood of being in cluster 1. Clusters with 3 or more compromised organs (4, 7, 
11, 12), all had use of vasopressors, need for mechanical ventilation and admission temperature 
as the most important variables defining membership based on their coefficients, whereas 
clusters 1 and 5 had vasopressor use and baseline creatinine.   
 
When comparing patterns of organ dysfunction, we initially based our analysis on the stipulated 
published data and definitions of multiple organ dysfunction. By these standards, patients with 2 
or more organs should be considered as having multiple organ dysfunction, regardless of how 
many organs are compromised beyond that definition. However, we found that patients with 2 
dysfunctional organs, were more similar with those presenting 1 organ failure, than with those 
presenting more than 2. We then compared these two groups and clearly found differences, not 
only in admission demographic and clinical data, but also in the involvement of specific vital 
signs and laboratory data that could hint towards possible mechanisms of disease. In essence we 
found that clusters 4, 7, 12 and 11, had a higher proportion of hypothermic, leukopenic and 
thrombocytopenic patients than clusters 1, 5 and 13, and more so than cluster 2. Although 
causality cannot be inferred from this study, these data does suggest a potential alteration in the 
immune, metabolic and endothelial response to injury, which is associated with further organ 
damage, longer stay and higher 90-day and 1-year death rates.  
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When we explored the differences between clusters of patients that developed renal, hematologic 
or hepatobiliary compromise, vs. those who only developed hepatobiliary or none, we found the 
same signature, with important influence of hypothermia in determining the sickest group. 
Surprisingly, baseline creatinine did not appear to have an effect on determining the 
characteristics of these patients or explaining the association with the involvement of these three 
organs. The strongest predictors of being in the group of renal, hematologic and hepatobiliary 
compromise (or “All”) from the multinomial logistic regression model were use of vasopressors, 
need for mechanical ventilation and body temperature (Appendix B2). Finally, the administration 
of fluids in the first 24 hours was clearly distinct between patients with renal, hematologic and 
hepatobiliary compromise, vs. Hep or None.  
 
This study has important limitations. First, although we attempted to use an unsupervised 
learning technique, and were careful to objectivize our methodology, it is true that subtle changes 
in the modeling may cause dramatic changes in the results, and thus this data requires validation 
and replication before drawing absolute conclusions. In addition, the analysis of this data does 
not provide use with enough tools as to derive associations between organ dysfunction patterns 
and mechanisms of disease. This is mainly due to the fact that the data set we used for derivation 
of this analysis did not include information on other possibly important variables like cytokines, 
chemokines, specific markers of tissue/organ damage, etc. We expect that this analysis will serve 
as the basis to explore such mechanistic questions in other databases that will contain such 
variables. Another limitation of our study is the use of a broad definition of sepsis. We chose to 
use a broad definition to be able to include all the spectrum of disease in our analysis. However, 
it is possible that in doing so, we included patients that did not fulfill strict clinical criteria for the 
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sepsis syndrome, but rather had a localized infection that of course behaves very differently in 
terms of organ compromise, clinical course and outcome. However, we may have captured most 
of these patients in cluster 2, and planned analysis will address this question in the future.  
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5.0  CONCLUSIONS 
The present study has demonstrated that an unsupervised clustering technique based on 
frequently collected demographic, clinical and physiologic data, can be used to interrogate the 
structure of a large database, and derive distinct and biologically sound clusters of patients. In 
essence, we have been able to derive specific phenotypes of patients with “suspected sepsis” who 
look clinically different in some aspects at admission to the ICU, but also, follow distinct 
trajectories in terms of number of dysfunctional organs, type of dysfunctional organs, length of 
stay and mortality.  
 
Although the design of the current study does not allow inferring causality, some of the findings 
suggest potential mechanisms explaining more or less, or even, specific patterns of organ 
involvement during “suspected sepsis”. More leukopenia, hypothermia and thrombocytopenia 
were related to higher number of compromised organs at 72 hours after admission to the ICU, all 
of which imply alterations in the immune and endothelial response to injury.  
 
Finally, this methodology provides an interesting tool to define distinct, clinically relevant 
phenotypes in a cohort of potentially septic patients. It serves as a starting point to select more 
specific patient populations, and explore diverse mechanisms of disease that may lead to specific 
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patterns of organ involvement, and may be determine susceptible populations to specific 
therapeutic strategies in the future.  
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APPENDIX A: DEFINITION OF COMORBIDITIES AND ORGAN DYSFUNCTION 
A1. CHARLSON-DEYO INDEX 
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A2. PRE-SPECIFIED RULES TO ASSESS ORGAN FUNCTION 
Table A2 shows the criteria we selected to define organ involvement. We adhered to published 
and validated criteria to define organ dysfunction from different models including the Sequential 
Organ Failure Assessment score (SOFA), RIFLE criteria for evaluation of AKI, as well as other 
criteria that represents importance in the clinical setting such as need for vasopressors or need for 
mechanical ventilation.  
Table A2. Criteria to define Organ dysfunction at 72 hours and 30 days 
Organ/system involved Variable Criteria Organ dysfunction if: 
Cardiovascular Lactate (mmol/L) Mild 2-3 72 h and 30 day: 
Moderate - Severe Moderate 3.1-4 
Severe >4 
Use of vasopressors Low < Avg 72 h and 30 day: 
Avg or >Avg Average Avg 
High > Avg 
Pulmonary Mechanical 
Ventilation 
Low < Avg 72 h and 30 day: 
Avg or >Avg Average Avg 
High > Avg 
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PaO2/FiO2 Mild 200-300 72 h and 30 day:  
Moderate - Severe Moderate 100-200 
Severe <100 
Renal Change in Cr 
(Based on RIFLE 
creatinine criteria) 
0 < 0.3mg/dL 72 h: R or I  
30 day: Persistent 
elevation > 0.3 mg/dL  
R > 0.3 mg/dL or 
1.5xBaseline 
I 2xbaseline 
RRT Low < Avg 72h: Avg or >Avg  
30 day: doubling 72h 
rate of use  
Average Avg 
High > Avg 
Hematology Change in Platelet 
count 
Mild < 25K 72 h: Severe  
30 day: < 150K  Moderate 25-50K 
Severe >50K 
Hepatobiliary Total Bilirrubin 
(Based on SOFA 
criteria) 
Mild 1.2-1.9 72 h and 30 day:  
Moderate - Severe Moderate 2-5.9 
Severe >6 
INR >1.5 72 h and 30 day:  
>1.5 
Avg=Average for the entire population. 
Table A2 Continued 
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APPENDIX B: MULTINOMIAL LOGISTIC REGRESSION 
B.1 MULTINOMIAL LOGISTIC REGRESSION FOR CLUSTER MEMBERSHIP 
The following is a multinomial logistic regression to assess the determinants of cluster 
membership. Cluster membership is identified in the analysis as QCL_1. All the variables used 
in this model were collected either at admission too the ICU (as first measure – i.e. first 
Temperature), or within the first 24 hours of admission (i.e. need for mechanical ventilation).  
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1 . mlogit QCL_1 last1yr_min_hosp_icu1_MDRD Ap3_1st24hrs_after_ICU1admit age wgt_
> kg Platelets_1stMeasure_after_ICU1_ WBC_1stMeasure_after_ICU1_admit Temp_1stM
> easure_after_ICU1_admit i.Sex_code i.vassop_24hrs_from_ICUd1 i.mv_24hrs_from_
> ICUd1, base(2)
Iteration 0:   log likelihood =  -6616.165  
Iteration 1:   log likelihood = -6110.1974  
Iteration 2:   log likelihood = -5983.0308  
Iteration 3:   log likelihood = -5969.7557  
Iteration 4:   log likelihood = -5966.3408  
Iteration 5:   log likelihood = -5964.6034  
Iteration 6:   log likelihood = -5964.2893  
Iteration 7:   log likelihood = -5964.2183  
Iteration 8:   log likelihood = -5964.2112  
Iteration 9:   log likelihood = -5964.2097  
Iteration 10:  log likelihood = -5964.2094  
Iteration 11:  log likelihood = -5964.2093  
Iteration 12:  log likelihood = -5964.2093  
Multinomial logistic regression                   Number of obs   =       3315
                                                  LR chi2(120)    =    1303.91
                                                  Prob > chi2     =     0.0000
Log likelihood = -5964.2093                       Pseudo R2       =     0.0985
       QCL_1       Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval]
1            
last1yr_mi~D    .2579879   .0883758     2.92   0.004     .0847746    .4312012
Ap3_1st24h~t    .0016129   .0066398     0.24   0.808     -.011401    .0146268
         age    .0078514   .0040984     1.92   0.055    -.0001814    .0158841
      wgt_kg    .0000108   .0027442     0.00   0.997    -.0053678    .0053894
Platelets~1_    .0003229   .0005375     0.60   0.548    -.0007306    .0013765
WBC_1stMea~t   -.0135697   .0099723    -1.36   0.174    -.0331149    .0059756
Temp_1stMe~t   -.2179836   .0534588    -4.08   0.000    -.3227609   -.1132063
  2.Sex_code   -.2334117   .1380681    -1.69   0.091    -.5040202    .0371969
1.vassop_2~1    .0064545   .1765525     0.04   0.971     -.339582    .3524909
1.mv_24hrs~1   -.4780162   .1360955    -3.51   0.000    -.7447584   -.2112739
       _cons    7.408298   2.099799     3.53   0.000     3.292768    11.52383
2              (base outcome)
3            
last1yr_mi~D    -.994431   .6723972    -1.48   0.139    -2.312305    .3234433
Ap3_1st24h~t    .0884194   .0143552     6.16   0.000     .0602837     .116555
         age   -.0364883   .0123909    -2.94   0.003     -.060774   -.0122025
      wgt_kg    .0074656   .0061492     1.21   0.225    -.0045867    .0195178
Platelets~1_   -.0035394   .0016921    -2.09   0.036    -.0068557    -.000223
WBC_1stMea~t    .0270984   .0134764     2.01   0.044     .0006852    .0535117
Temp_1stMe~t   -.0449411   .1341549    -0.33   0.738    -.3078799    .2179976
  2.Sex_code    .2970106    .432482     0.69   0.492    -.5506385     1.14466
1.vassop_2~1    1.531629   .5423567     2.82   0.005     .4686296    2.594629
1.mv_24hrs~1    17.50022   1929.076     0.01   0.993    -3763.419    3798.419
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       _cons   -24.60476   1929.083    -0.01   0.990    -3805.538    3756.329
4            
last1yr_mi~D   -.0649433   .1458423    -0.45   0.656    -.3507889    .2209023
Ap3_1st24h~t    .0852312   .0073639    11.57   0.000     .0707981    .0996642
         age   -.0197739   .0054445    -3.63   0.000    -.0304448   -.0091029
      wgt_kg    .0046003    .003273     1.41   0.160    -.0018147    .0110152
Platelets~1_   -.0048439    .000846    -5.73   0.000     -.006502   -.0031857
WBC_1stMea~t     .007554   .0108196     0.70   0.485    -.0136519      .02876
Temp_1stMe~t    -.200504   .0647012    -3.10   0.002     -.327316    -.073692
  2.Sex_code   -.0310781   .1852993    -0.17   0.867     -.394258    .3321017
1.vassop_2~1    1.248666   .2228015     5.60   0.000     .8119829    1.685349
1.mv_24hrs~1    1.225474   .2474216     4.95   0.000     .7405369    1.710412
       _cons   -1.023732   2.586609    -0.40   0.692    -6.093393    4.045929
5            
last1yr_mi~D    .2549779   .0842516     3.03   0.002     .0898478    .4201081
Ap3_1st24h~t    .0294701   .0057714     5.11   0.000     .0181584    .0407817
         age    .0035735    .003732     0.96   0.338    -.0037411    .0108881
      wgt_kg    .0037184   .0023659     1.57   0.116    -.0009187    .0083555
Platelets~1_   -.0014178   .0005103    -2.78   0.005     -.002418   -.0004175
WBC_1stMea~t    .0215602   .0080795     2.67   0.008     .0057246    .0373957
Temp_1stMe~t   -.1935092      .0502    -3.85   0.000    -.2918994   -.0951189
  2.Sex_code   -.2377234    .125326    -1.90   0.058    -.4833579    .0079111
1.vassop_2~1    .5098352   .1497216     3.41   0.001     .2163863    .8032841
1.mv_24hrs~1    .5996156   .1290928     4.64   0.000     .3465983    .8526328
       _cons    3.688225   1.961814     1.88   0.060    -.1568598     7.53331
6            
last1yr_mi~D   -.7240373   1.922957    -0.38   0.707    -4.492964    3.044889
Ap3_1st24h~t     .006823   .0619719     0.11   0.912    -.1146397    .1282858
         age    .0163726   .0519979     0.31   0.753    -.0855414    .1182866
      wgt_kg    .0275128   .0183873     1.50   0.135    -.0085257    .0635512
Platelets~1_    .0076743   .0060461     1.27   0.204    -.0041758    .0195244
WBC_1stMea~t   -.1328506   .1369248    -0.97   0.332    -.4012182    .1355171
Temp_1stMe~t   -.6691069   .4119941    -1.62   0.104    -1.476601    .1383867
  2.Sex_code    16.11756   2263.238     0.01   0.994    -4419.748    4451.983
1.vassop_2~1    17.16397   2335.924     0.01   0.994    -4561.162     4595.49
1.mv_24hrs~1    14.82352   2198.038     0.01   0.995    -4293.252    4322.899
       _cons   -30.47733   3925.613    -0.01   0.994    -7724.538    7663.583
7            
last1yr_mi~D   -.0998418   .2261044    -0.44   0.659    -.5429984    .3433147
Ap3_1st24h~t    .0956655   .0100401     9.53   0.000     .0759872    .1153438
         age   -.0317379    .008002    -3.97   0.000    -.0474215   -.0160544
      wgt_kg   -.0063246    .005532    -1.14   0.253    -.0171671    .0045179
Platelets~1_   -.0047187   .0012119    -3.89   0.000    -.0070939   -.0023434
WBC_1stMea~t    .0284539   .0105666     2.69   0.007     .0077438     .049164
Temp_1stMe~t   -.1923171    .088448    -2.17   0.030     -.365672   -.0189623
  2.Sex_code    .7298071   .2964198     2.46   0.014      .148835    1.310779
1.vassop_2~1    1.277474   .3556348     3.59   0.000     .5804429    1.974506
1.mv_24hrs~1    2.162631   .6065891     3.57   0.000     .9737382    3.351524
       _cons   -3.564225   3.609357    -0.99   0.323    -10.63843    3.509984
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8            
last1yr_mi~D   -.2773051    1.20194    -0.23   0.818    -2.633064    2.078454
Ap3_1st24h~t    .1487964   .0617574     2.41   0.016     .0277542    .2698387
         age   -.0590412    .061134    -0.97   0.334    -.1788616    .0607792
      wgt_kg    .0378743   .0194945     1.94   0.052    -.0003342    .0760828
Platelets~1_   -.0302423    .018462    -1.64   0.101    -.0664272    .0059427
WBC_1stMea~t   -.1016881   .1335816    -0.76   0.447    -.3635032    .1601271
Temp_1stMe~t   -.8147279   .5590123    -1.46   0.145    -1.910372    .2809162
  2.Sex_code   -.4523989   1.575728    -0.29   0.774    -3.540769    2.635971
1.vassop_2~1   -1.866611   2.136049    -0.87   0.382     -6.05319    2.319967
1.mv_24hrs~1    21.69209   826.2883     0.03   0.979    -1597.803    1641.187
       _cons   -5.993347   826.1564    -0.01   0.994     -1625.23    1613.244
9            
last1yr_mi~D   -15.78202   13.90348    -1.14   0.256    -43.03235    11.46831
Ap3_1st24h~t   -.1231165   .1364632    -0.90   0.367    -.3905794    .1443465
         age    .0767384   .0956515     0.80   0.422     -.110735    .2642119
      wgt_kg   -.1585233   .1066732    -1.49   0.137     -.367599    .0505524
Platelets~1_   -.0215735   .0165433    -1.30   0.192    -.0539978    .0108507
WBC_1stMea~t   -.1201377   .2621024    -0.46   0.647     -.633849    .3935736
Temp_1stMe~t   -1.269956    1.06334    -1.19   0.232    -3.354064    .8141525
  2.Sex_code    19.54214   2165.609     0.01   0.993    -4224.973    4264.057
1.vassop_2~1   -13.13544   1560.886    -0.01   0.993    -3072.416    3046.145
1.mv_24hrs~1    15.26587   2374.795     0.01   0.995    -4639.248    4669.779
       _cons    38.58915   1921.553     0.02   0.984    -3727.586    3804.764
10           
last1yr_mi~D   -.0337378   .2881904    -0.12   0.907    -.5985806     .531105
Ap3_1st24h~t    .0063434   .0164481     0.39   0.700    -.0258944    .0385812
         age   -.0127597   .0101505    -1.26   0.209    -.0326543     .007135
      wgt_kg   -.0094978   .0079714    -1.19   0.233    -.0251215     .006126
Platelets~1_    .0013789   .0012511     1.10   0.270    -.0010731     .003831
WBC_1stMea~t   -.0021322   .0238796    -0.09   0.929    -.0489353    .0446709
Temp_1stMe~t   -.2149521   .1346991    -1.60   0.111    -.4789576    .0490533
  2.Sex_code    .9225516   .3949488     2.34   0.019     .1484661    1.696637
1.vassop_2~1    .5761773    .415864     1.39   0.166    -.2389013    1.391256
1.mv_24hrs~1    .1687425   .3594363     0.47   0.639    -.5357397    .8732246
       _cons    5.162864    5.31817     0.97   0.332    -5.260558    15.58629
11           
last1yr_mi~D    .1373414   .0870959     1.58   0.115    -.0333634    .3080461
Ap3_1st24h~t    .0452444   .0056107     8.06   0.000     .0342477    .0562411
         age   -.0115037   .0036077    -3.19   0.001    -.0185746   -.0044328
      wgt_kg    .0032525   .0023085     1.41   0.159     -.001272     .007777
Platelets~1_   -.0020228   .0005107    -3.96   0.000    -.0030239   -.0010218
WBC_1stMea~t     .002741   .0083076     0.33   0.741    -.0135415    .0190235
Temp_1stMe~t   -.2143657   .0486574    -4.41   0.000    -.3097324    -.118999
  2.Sex_code   -.0309439   .1231993    -0.25   0.802      -.27241    .2105223
1.vassop_2~1    .5006962   .1471652     3.40   0.001     .2122576    .7891348
1.mv_24hrs~1    .6640347   .1275476     5.21   0.000     .4140459    .9140234
       _cons    4.503861   1.900447     2.37   0.018     .7790523    8.228669
12           
last1yr_mi~D    .0545929   .1054669     0.52   0.605    -.1521186    .2613043
 66 
 
 
B.2 MULTINOMIAL LOGISTIC REGRESSION FOR MEMBERSHIP TO “ALL”, 
“HEP” OR “NONE” GROUPS 
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Ap3_1st24h~t    .0578056   .0063112     9.16   0.000     .0454359    .0701753
         age   -.0198908   .0043203    -4.60   0.000    -.0283585   -.0114232
      wgt_kg    .0020003   .0027102     0.74   0.460    -.0033116    .0073122
Platelets~1_   -.0038153    .000639    -5.97   0.000    -.0050677    -.002563
WBC_1stMea~t    .0177297     .00887     2.00   0.046     .0003448    .0351146
Temp_1stMe~t   -.1410701    .056615    -2.49   0.013    -.2520334   -.0301068
  2.Sex_code    -.021382   .1472752    -0.15   0.885     -.310036     .267272
1.vassop_2~1    1.316855   .1717599     7.67   0.000     .9802121    1.653498
1.mv_24hrs~1    1.126434   .1733581     6.50   0.000     .7866581     1.46621
       _cons     .007581   2.225089     0.00   0.997    -4.353513    4.368675
13           
last1yr_mi~D   -.3211752    .181484    -1.77   0.077    -.6768774     .034527
Ap3_1st24h~t    .0190424   .0080497     2.37   0.018     .0032652    .0348196
         age    -.009812   .0051427    -1.91   0.056    -.0198915    .0002674
      wgt_kg    -.005145   .0036721    -1.40   0.161    -.0123422    .0020522
Platelets~1_   -.0024909    .000761    -3.27   0.001    -.0039824   -.0009994
WBC_1stMea~t    .0147005   .0112979     1.30   0.193     -.007443     .036844
Temp_1stMe~t    .0373748    .072755     0.51   0.607    -.1052225    .1799721
  2.Sex_code   -.0112487   .1799187    -0.06   0.950    -.3638828    .3413854
1.vassop_2~1    .6993275   .2074031     3.37   0.001     .2928249     1.10583
1.mv_24hrs~1    .1925977   .1804077     1.07   0.286    -.1609948    .5461902
       _cons    -2.67047   2.827676    -0.94   0.345    -8.212614    2.871674
2 . 
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1 . mlogit  RenHemHepDysf Platelets_1stMeasure_after_ICU1_ Hb_1stMeasure_after_IC
> U1_admit pH_1stMeasure_after_ICU1_admit  WBC_1stMeasure_after_ICU1_admit Temp
> _1stMeasure_after_ICU1_admit BD_1stMeasure_after_ICU1_admit i.Sex_code  i.vas
> sop_24hrs_from_ICUd1 i.vassop_24hrs_from_ICUd1 mv_24hrs_from_ICUd1, base(.)
Iteration 0:   log likelihood = -914.94822  
Iteration 1:   log likelihood = -818.97132  
Iteration 2:   log likelihood = -818.82466  
Iteration 3:   log likelihood = -818.82464  
Multinomial logistic regression                   Number of obs   =       1320
                                                  LR chi2(9)      =     192.25
                                                  Prob > chi2     =     0.0000
Log likelihood = -818.82464                       Pseudo R2       =     0.1051
RenHemHepD~f       Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval]
1            
Platelets~1_   -.0016792   .0005452    -3.08   0.002    -.0027477   -.0006107
Hb_1stMeas~t   -.0273172   .0254006    -1.08   0.282    -.0771015    .0224671
pH_1stMeas~t    1.111628   .7344976     1.51   0.130    -.3279606    2.551217
WBC_1stMea~t    .0063664   .0068448     0.93   0.352    -.0070492     .019782
Temp_1stMe~t    .1077261   .0441077     2.44   0.015     .0212767    .1941756
BD_1stMeas~t    .0922664   .0138995     6.64   0.000      .065024    .1195089
  2.Sex_code    .1811615   .1223405     1.48   0.139    -.0586216    .4209445
1.vassop_2~1    .8596238   .1270366     6.77   0.000     .6106366    1.108611
mv_24hrs_f~1    .7739445   .1762279     4.39   0.000     .4285443    1.119345
       _cons   -13.33266   5.586158    -2.39   0.017    -24.28132   -2.383989
2              (base outcome)
2 . 
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